JGC
BLU

J. Goldman & Co’s BELLUS Health Inc. BLU Stock Holding History

J. Goldman & Co’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-54,000
Closed -$389K – 528
2023
Q1 		$389K Sell
54,000
-131,575
-71% -$1.02M 0.02% 285
2022
Q4 		$1.53M Buy
185,575
+106,717
+135% +$995K 0.07% 193
2022
Q3 		$833K Buy
78,858
+33,852
+75% +$360K 0.04% 266
2022
Q2 		$416K Sell
45,006
-69,444
-61% -$568K 0.02% 290
2022
Q1 		$787K Sell
114,450
-85,356
-43% -$550K 0.04% 269
2021
Q4 		$1.61M Buy
+199,806
New +$1.33M 0.09% 225

Other funds holding BLU

CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
Canada Life
Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

J. Goldman & Co's BLU Position: Q2 2023 in Review

J. Goldman & Co sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 54,000 shares — an estimated $389K sold.

J. Goldman & Co first reported a position in BLU in Q4 2021 and held it in 6 quarters. The position peaked at $1.61M in Q4 2021. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

  • J. Goldman & Co reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
  • J. Goldman & Co sold 54,000 BELLUS Health Inc. shares in Q2 2023, an estimated $389K.
  • J. Goldman & Co first reported a position in BELLUS Health Inc. in Q4 2021 and held it in 6 quarters.
  • J. Goldman & Co's BELLUS Health Inc. position peaked at $1.61M in Q4 2021.
  • 11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on J. Goldman & Co's 13F filing for Q2 2023, filed 14 Aug 2023.